NDC 63548-0197-08 - Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63548-0197
- Requested NDC
- 63548-0197-08
- Package NDCs from labels
- 63548-0197-2, 63548-0197-8, 63548-0197-3, 63548-0197-08
- Manufacturer
- PLD Acquisitions LLC DBA Avéma Pharma Solutions
- Effective date
- 2024-04-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IBUPROFEN - PLD Acquisitions LLC DBA Avéma Pharma Solutions | PLD Acquisitions LLC DBA Avéma Pharma Solutions | 2024-04-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63548-0197-2 | Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg | 1 in 1 BOX | TABLET | 1 | 6 | |
| 63548-0197-2 | Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 6 | |
| 63548-0197-3 | Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg | 300 in 1 BOTTLE, PLASTIC | TABLET | 300 | 6 | |
| 63548-0197-8 | Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg | 8 in 1 BOTTLE, PLASTIC | TABLET | 8 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63548-0197 | IBUPROFEN 200 MG AND DIPHENHYDRAMINE CITRATE 38 MG (IBUPROFEN, DIPHENHYDRAMINE CITRATE) TABLET [PLD ACQUISITIONS LLC DBA AVÉMA PHARMA SOLUTIONS] | 6 | Current NDC, 4 package rows | 20240426_a7d729bf-6d7a-415a-a414-cae0ba6d0063.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.